Literature DB >> 16644173

Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.

Hui-Liang Li1, Wei-Dong Zhang, Chuan Zhang, Run-Hui Liu, Xiang-Wei Wang, Xiao-Lin Wang, Jian-Bao Zhu, Chun-Lin Chen.   

Abstract

Corydalis saxicola Bunting (Yanhuanglian) is an important component in various prescriptions in traditional Chinese medicine. Yanhuanglian has been demonstrated to possess many pharmacological activities, including antibacterial, antiviral and anticancer activities. The active fractions are dehydrocavidine, coptisine, dehydroapocavidine and tetradehydroscoulerine. The purpose of the present study was to examine in vivo pharmacokinetics and tissue distribution in rats by using high-performance liquid chromatography (HPLC) coupled with tandem mass spectrometry. Systemic clearance of the four active alkaloids in plasma was over 93% of hepatic blood flow, indicating they may be quickly eliminated via hepatic clearance. Less than 10% drugs was excreted via urine following intravenous and oral administration, suggesting that these four alkaloids may undergo significant metabolism in the body or the drug may be excreted via other routes other than urine. There was significantly lower excretion of these four alkaloids following oral than intravenous administration, suggesting a significant first pass effect after oral administration. There appeared to be wide distribution of those four alkaloids in rats as demonstrated by the higher apparent volume of distribution. Our results have also demonstrated that the four alkaloids can be absorbed following oral administration although there were less than 15% of drugs absorbed into systemic circulation. In summary, the favorable oral bioavailability properties of those four active alkaloids in rats make Yanhuanglian extract worth further investigation for improving oral bioavailability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644173     DOI: 10.1016/j.jpba.2006.03.029

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  5 in total

1.  Pharmacokinetic optimization of 4-substituted methoxybenzoyl-aryl-thiazole and 2-aryl-4-benzoyl-imidazole for improving oral bioavailability.

Authors:  Chien-Ming Li; Jianjun Chen; Yan Lu; Ramesh Narayanan; Deanna N Parke; Wei Li; Sunjoo Ahn; Duane D Miller; James T Dalton
Journal:  Drug Metab Dispos       Date:  2011-07-08       Impact factor: 3.922

2.  Alternative medicine products as a novel treatment strategy for inflammatory bowel disease.

Authors:  Lindsey N Jackson; Yuning Zhou; Suimin Qiu; Qingding Wang; B Mark Evers
Journal:  Am J Chin Med       Date:  2008       Impact factor: 4.667

Review 3.  The Traditional Uses, Phytochemistry, Pharmacokinetics, Pharmacology, Toxicity, and Applications of Corydalis saxicola Bunting: A Review.

Authors:  Yanru Guo; Linjun Zhao; Botao Chang; Jia Yu; Jiangping Bao; Qi Yao; Jun Luo
Journal:  Front Pharmacol       Date:  2022-02-16       Impact factor: 5.810

4.  System Pharmacology-Based Dissection of the Synergistic Mechanism of Huangqi and Huanglian for Diabetes Mellitus.

Authors:  Shi-Jun Yue; Juan Liu; Wu-Wen Feng; Fei-Long Zhang; Jian-Xin Chen; Lan-Ting Xin; Cheng Peng; Hua-Shi Guan; Chang-Yun Wang; Dan Yan
Journal:  Front Pharmacol       Date:  2017-10-05       Impact factor: 5.810

Review 5.  The Biological Activity of Natural Alkaloids against Herbivores, Cancerous Cells and Pathogens.

Authors:  Amin Thawabteh; Salma Juma; Mariam Bader; Donia Karaman; Laura Scrano; Sabino A Bufo; Rafik Karaman
Journal:  Toxins (Basel)       Date:  2019-11-11       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.